Want to join the conversation?
$MDCO entered into a new strategic partnership with the Biomedical Advanced Research and Development Authority (BARDA). The partnership was established under U.S. Department of Health and Human Services' (HHS) Other Transactional Authority (OTA) and is a distinctive, flexible, portfolio-based approach to funding drug development.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.